ClearBridge Investments’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,045,918
Closed -$8.69M 737
2024
Q3
$8.69M Sell
1,045,918
-8,191
-0.8% -$70.8K 0.01% 544
2024
Q2
$7.55M Buy
1,054,109
+253,887
+32% +$2.19M 0.01% 562
2024
Q1
$6.94M Buy
800,222
+21,200
+3% +$143K 0.01% 568
2023
Q4
$5.1M Sell
779,022
-2,300,571
-75% -$14.9M ﹤0.01% 579
2023
Q3
$30.8M Sell
3,079,593
-28,370
-0.9% -$312K 0.03% 376
2023
Q2
$38.6M Sell
3,107,963
-132,200
-4% -$1.78M 0.03% 354
2023
Q1
$45.4M Buy
3,240,163
+42,052
+1% +$604K 0.04% 332
2022
Q4
$45.8M Buy
3,198,111
+222,376
+7% +$3.5M 0.05% 329
2022
Q3
$76M Buy
2,975,735
+267,860
+10% +$6.72M 0.08% 239
2022
Q2
$76.9M Buy
2,707,875
+277,260
+11% +$8.78M 0.07% 251
2022
Q1
$85.7M Sell
2,430,615
-235,082
-9% -$7.88M 0.06% 272
2021
Q4
$112M Buy
2,665,697
+11,171
+0.4% +$453K 0.08% 230
2021
Q3
$130M Buy
2,654,526
+55,397
+2% +$2.7M 0.09% 202
2021
Q2
$108M Buy
2,599,129
+1,045,382
+67% +$40.5M 0.08% 227
2021
Q1
$55.4M Buy
1,553,747
+348,492
+29% +$11.5M 0.04% 336
2020
Q4
$33.8M Buy
+1,205,255
New +$33.6M 0.03% 390

Other funds holding MRVI

ClearBridge Investments's MRVI Position: Q4 2024 in Review

ClearBridge Investments sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 1,045,918 shares — an estimated $8.69M sold.

ClearBridge Investments first reported a position in MRVI in Q4 2020 and held it in 16 quarters. The position peaked at $130M in Q3 2021. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • ClearBridge Investments reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • ClearBridge Investments sold 1,045,918 Maravai LifeSciences shares in Q4 2024, an estimated $8.69M.
  • ClearBridge Investments first reported a position in Maravai LifeSciences in Q4 2020 and held it in 16 quarters.
  • ClearBridge Investments's Maravai LifeSciences position peaked at $130M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on ClearBridge Investments's 13F filing for Q4 2024, filed 12 Feb 2025.